Frances Grudzinska

Medicine & Life Sciences

1. Neutrophils 100%
2. Pneumonia 74%
3. E-Cigarette Vapor 30%
4. Sepsis 27%
5. Observational Studies 26%
6. Respiratory Burst 21%
7. Healthcare-Associated Pneumonia 20%
8. Hydroxymethylglutaryl-CoA Reductase Inhibitors 20%
9. Simvastatin 18%
10. Alveolar Macrophages 17%
11. Phenotype 17%
12. Nicotine 17%
13. Tobacco Products 16%
14. Phagocytosis 15%
15. Extracellular Traps 13%
16. Actins 13%
17. Early Warning Score 12%
18. Cell-Free Nucleic Acids 10%
19. Cohort Studies 10%
20. Randomized Controlled Trials 10%
21. Retrospective Studies 10%
22. Infections 10%
23. SARS Virus 10%
24. Chemotaxis 9%
25. Macrolides 9%
26. Electronic Nicotine Delivery Systems 8%
27. Ventilator-Associated Pneumonia 8%
28. Therapeutics 8%
29. Vascular Endothelial Growth Factor A 7%
30. Mortality 7%
31. Interleukin-6 7%
32. Placebos 7%
33. Hospitalization 7%
34. Vaping 7%
35. Organ Dysfunction Scores 7%
36. Critical Care 6%
37. Anti-Bacterial Agents 6%
38. Cell Surface Receptors 5%
39. Glycolysis 5%
40. Health 5%